Patent Category: Therapies

8-(octadecylsulfanyl)quinoline for use as a drug, especially for use in the treatment and prevention of the development of insulin resistance

A subject of the invention is a compound 8-(octadecylsulfanyl)quinoline for use as a drug, especially for use in the treatment and prevention of the development of insulin resistance. The invention also relates to a pharmaceutical composition containing 8-(octadecylsulfanyl)quinoline as an active ingredient, and to the use of 8-(octadecylsulfanyl)quinoline for the manufacture of a drug for the prevention of insulin resistance. Patent was granted in Poland. Nencki Institute is the ...